Correlation Between Hemogenyx Pharmaceuticals and Dow Jones

Can any of the company-specific risk be diversified away by investing in both Hemogenyx Pharmaceuticals and Dow Jones at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hemogenyx Pharmaceuticals and Dow Jones into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Hemogenyx Pharmaceuticals Plc and Dow Jones Industrial, you can compare the effects of market volatilities on Hemogenyx Pharmaceuticals and Dow Jones and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hemogenyx Pharmaceuticals with a short position of Dow Jones. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hemogenyx Pharmaceuticals and Dow Jones.

Diversification Opportunities for Hemogenyx Pharmaceuticals and Dow Jones

-0.23

Correlation Coefficient

Hemogenyx Pharmaceuticals  Dow Jones

Very good diversification

The 3 months correlation between Hemogenyx and Dow is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Hemogenyx Pharmaceuticals Plc and Dow Jones Industrial in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dow Jones Industrial and Hemogenyx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hemogenyx Pharmaceuticals Plc are associated (or correlated) with Dow Jones. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dow Jones Industrial has no effect on the direction of Hemogenyx Pharmaceuticals i.e., Hemogenyx Pharmaceuticals and Dow Jones go up and down completely randomly.

Pair Corralation between Hemogenyx Pharmaceuticals and Dow Jones

If you would invest  124.00  in Hemogenyx Pharmaceuticals Plc on October 11, 2024 and sell it today you would earn a total of  0.00  from holding Hemogenyx Pharmaceuticals Plc or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	90.91%
Values	Daily Returns

Hemogenyx Pharmaceuticals Plc  vs.  Dow Jones Industrial

Pair Trading with Hemogenyx Pharmaceuticals and Dow Jones

The main advantage of trading using opposite Hemogenyx Pharmaceuticals and Dow Jones positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hemogenyx Pharmaceuticals position performs unexpectedly, Dow Jones can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dow Jones will offset losses from the drop in Dow Jones' long position.

The idea behind Hemogenyx Pharmaceuticals Plc and Dow Jones Industrial pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.